HR Execs on the Move

Xenon Pharmateuticals

www.xenon-pharma.com

 
Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders. At Xenon, we are advancing an exciting pipeline of neurology-focused therapies, with a particular emphasis on novel treatments for both adult and pediatric patients with epilepsy. XEN496 is currently being evaluated in the Phase 3 “EPIK” clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy. Late-stage development plans are also underway for our XEN1101 program, building upon the compelling ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Helen Shin
Director, Human Resources Profile
Simon Pimstone
Chief Executive Officer Profile
Shelley McCloskey
Senior Vice President of Human Resources Profile

Similar Companies

Hexagon Labs

Hexagon Labs is a Monmouth Junction, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ELPRO SERVICES

ELPRO SERVICES is a Marietta, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Encompass Group

For nearly a century, Encompass has been helping health care and hospitality organizations create safe, comfortable environments for patients, staff, residents and guests. Whether developing advanced hypothermia prevention products, helping hospitals contain the spread of infections, or designing interiors for new, state-of-the-art retirement communities, we offer a complete line of products, services and education programs that meet the challenges our customers face every day.

The Royal Women's Hospital

The Royal Womens Hospital is Australias largest specialist hospital dedicated to improving the health of women of all ages and newborn babies. They provide comprehensive services ranging from health promotion to clinical expertise and leadership in m...

PolyNovo Limited

At PolyNovo we are driven by improving the outcomes of patients through development and provision of the best surgical solutions possible. PolyNovo develops innovative medical devices utilizing the patented bioabsorbable polymer technology Novosorb®. NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products via established pathways. NovoSorb BTM (Biodegradable Temporizing Matrix) is the first product commercialized by PolyNovo. In 2015, following the FDA 510(K) clearance of BTM, PolyNovo was awarded an $11 million contract and a further $25 million in funding from the US-based Biomedical Advanced Research and Development Authority (BARDA) to complete a trial with BTM for full thickness burns. We have expanded our manufacturing facility and headquarters in Melbourne, Australia, establishing high quality processes, enabling product innovation and preparing for growth.